Ventyx Biosciences Financial Overview
Ventyx Biosciences's market cap is currently $666.49M. The company's EPS TTM is $-0.32; its P/E ratio is -6.05; Ventyx Biosciences is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
